Efficacy of artemisinin and its derivatives in animal models of type 2 diabetes mellitus: A systematic review and meta-analysis.

Wu, Tingchao; Feng, Haoyue; He, Mingmin; Yue, Rensong; Wu, Shaoqi

Wu, Tingchao; Feng, Haoyue; He, Mingmin; Yue, Rensong; Wu, Shaoqi.

Afiliação

Wu T; Hospital of Chengdu University of Traditional Chinese Medicine, Chengdu, Sichuan, China. Electronic address: 513025801@qq.com.
Feng H; Hospital of Chengdu University of Traditional Chinese Medicine, Chengdu, Sichuan, China. Electronic address: fenghaoyue@stu.cdutcm.edu.cn.
He M; Hospital of Chengdu University of Traditional Chinese Medicine, Chengdu, Sichuan, China. Electronic address: 279549910@qq.com.
Yue R; Hospital of Chengdu University of Traditional Chinese Medicine, Chengdu, Sichuan, China. Electronic address: songrenyue@cdutcm.edu.cn.
Wu S; Ningxia Medical University, Yinchuan, Ningxia, China. Electronic address: 597750884@qq.com.

Pharmacol Res ; 175: 105994, 2022 01.

Article em En | MEDLINE | ID: mdl-34808366

Assuntos

Artemisininas/uso terapêutico; Diabetes Mellitus Experimental/tratamento farmacológico; Diabetes Mellitus Tipo 2/tratamento farmacológico; Hipoglicemiantes/uso terapêutico; Animais; Resultado do Tratamento

Palavras-chave

Animal models; Artemether (PubChem CID: 68911); Artemisinin; Artemisinin (PubChem CID: 68827); Artemisinin derivatives; Artesunate (PubChem CID: 6917864); Meta-analysis; Type 2 diabetes mellitus

Texto completo

Imprimir

XML

PubMed Links

Buscar no Google

Texto completo: 1 Coleções: 01-internacional Base de dados: MEDLINE Assunto principal: Artemisininas / Diabetes Mellitus Experimental / Diabetes Mellitus Tipo 2 / Hipoglicemiantes Tipo de estudo: Prognostic_studies / Systematic_reviews Limite: Animals Idioma: En Revista: Pharmacol Res Assunto da revista: FARMACOLOGIA Ano de publicação: 2022 Tipo de documento: Article

Texto completo

Imprimir

XML

PubMed Links

Buscar no Google